ATOUT CAPITAL has advised ALPHA MOS on its fundraising of 5.3m via public offer with shareholders pre-emptive subscription rights being maintained, on Euronext Paris. The offer has been warmly welcomed with a subscription rate greater than 105%, allowing the extension clause activation. The success of this fundraising will enable ALPHA MOS to strengthen its financial resources in order to assert itself as a major player of the diagnostic and the medical and industrial quality control industry, particularly thanks to its unique electronic nose and tongue solution. This transaction has been supported by ALPHA MOS™’s main shareholders, the FCPI JOLT TARGETED OPPORTUNITIES, represented by the management company JOLT CAPITAL and AMBROSIA INVESTMENTS AM SARL.
